Short communication: Intermediate prevalence of HIV type 1 primary antiretroviral resistance in Ceará State, Northeast Brazil

AIDS Research and Human Retroviruses

Volumn 27, Issue 2, 2011, Pages 153-156

  Arruda, Érico ^a   Simões, Leda ^b   Sucupira, Cecília ^c   Medeiros, Melissa ^a,b,c,d   Arruda, Eurico ^e   Diaz, Ricardo S ^c   Lima, Aldo ^f  

^a Hospital Sao Jose de Doencas Infecciosas   (Brazil)

^b Nutrition School   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Centro de Especialidades Médicas José de Alencar   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; POL PROTEIN; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; BRAZIL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, VIRAL; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 79951718642     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0028     Document Type: Article

References (28)

1. Brasil. Ministério da Saú de, Secretaria de Vigilância em Saú de, Programa Nacional de DST e Aids. Boletim Epidemiolo ́ gico, Aids e DST: Ano V, no. 1, 27a- 52a , semanas epidemioló gicas, julho a dezembro de 2007 e Ano V, no. 1, 01a- 26a, semanas epidemioló gicas, janeiro a junho de 2008. Ministério da Saú de, Brasília, 2008. http://www.aids.gov .br/data/documents/ storedDocuments/%7BB8EF5DAF-23AE- 4891-AD36-1903553A3174%7D/%7B31A56BC6-307D- 4C88- 922D-6F52338D0BF4%7D/Boletim2008-vers%E3o1-6.pdf. Accessed 16 July, 2010.
2. Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, et al.: Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): A survey of chronically infected individuals. AIDS 2003;17:1063-1069. (Pubitemid 36549719)
3. Inocencio LA, Pereira AA, Sucupira MAC, Fernandez JCC, Jorge CP, Souza DFC, et al.: Brazilian Network for HIV Drug Resistance Surveillance: A survey of individuals recently diagnosed with HIV. J Int AIDS Soc 2009;12:20.
4. Sucupira MCA, Caseiro MM, Alves K, Tescarollo, Janini LM, Sabino EC, et al.: High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. AIDS Patient Care STDs 2007;21(2):116-128. (Pubitemid 46394455)
5. Bello G, Guimaraes ML, and Morgado MG: Evolutionary history of HIV-1 subtype B and F infections in Brazil. AIDS 2006;20:763-768. (Pubitemid 43890654)
6. Pedroso C, Queiroz ATL, Alcântara LC, Drexler JF, Diaz RS, Wey N, et al.: High prevalence of primary antiretroviral resistance among HIV-1-infected adults and children in Bahia, a Northeast State of Brazil. J Acquir Immune Defic Syndr 2007;45(2):251-252.
7. QIAamp Viral RNA Mini Handbook, 2nd ed. December 2005. Quiagen, Inc., Duesseldorf, Germany.
8. Medeiros LB, Lacerda HR, Cavalcanti AMS, Albuquerque MFPM. Primary resistance of human immunodeficiency virus Type 1 in a reference center in Recife, Pernambuco, Brazil. Mem Inst Oswaldo Cruz 2006; 10:845-849. (Pubitemid 46131332)
9. Instruções de Uso. Trugene HIV-1 Genotyping Kit: Para uso com o Opengene DNA Sequencing System. Rev. C. October 2004. Siemens Medical Solutions Diagnostics, Berkeley, CA.
10. Sucupira MC, Souza IE, Costa LJ, Scheinberg MA, and Diaz RS: Antiretroviral treatment failure and HIV-1 genotypic resistance in Sao Paulo, Brazil. Antivir Ther 2001;6(4):263-264. (Pubitemid 34174765)
11. Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuc M, et al.: Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS ONE 2009;4(3):e4724. doi:10.1371/journal. pone.
12. CDC: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(RR-17).
13. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde: Programa Nacional de DST e Aids. Critérios de Definic ̧ão de Casos de Aids em Adultos e Crianças. PN-DST/ Aids. Ministério da saúde, Brasília, 2003. http://www.aids.
14. gov.br/data/documents/storedDocuments/%7BB8EF5DAF- 23AE-4891-AD36- 1903553A3174%7D/%7B6C99F8D6-CC7B- 4D09-BECD-1AA2C7E7B587%7D/criterios-aids-2004. pdf. Accessed 16 July, 2010.
15. Ceará. Secretaria da Saúde: Coordenadoria de Promoção e Proteção à Saúde. Nú cleo de Epidemiologia. Informe Epidemiolo ́ gico, AIDS.Maio. Fortaleza, 2010. http://www.saude.ce. gov.br/site/index.php?option=com- phocadownload&view= category&id=9:boletins&Itemid=247. Accessed 16 July, 2010.
16. Medeiros R, Diaz RS, and Castelo A: Estimating the length of the first antiretroviral therapy regimen durability in Sao Paulo, Brazil. Braz J Infect Dis 2002;6(6):298-304.
17. Sprinz E, Netto EM, Lima MPJS, Furtado JD, Eira M, Zajdenverg R, et al.: Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil. Aids Res Hum Retroviruses 2009;25(9):861-867.
18. Petroni A, Deluchi G, Pryluka D, Rotryng F, Bortolozzi R, Lopardo G, et al.: Update on primary HIV-1 resistance in Argentina: Emergence of mutations conferring high-level resistance to nucleoside reverse transcriptase inhibitors in drug-naïve patients. J Acquir Immune Defic Syndr 2006;42:506-510. (Pubitemid 44050902)
19. Lama JR, Sanchez J, Suarez L, Caballero P, Laguna A, Sanchez JL, et al.: Linking HIV and antiretroviral drug resistance surveilance in Peru: A model for a third generation sentinel surveillance. J Acquir Immune Defic Syndr 2006; 42:501-505. (Pubitemid 44050901)
20. Pérez L, Á lvarez LP, Carmona R, Aragonés C, Delgado E, Thomson MM, et al.: Genotypic resistance to antiretroviral drugs in patients infectedwith severalHIVtype 1 genetic forms in Cuba. Aids Res Human Retroviruses 2007;23(3):407-414. (Pubitemid 46608561)
21. Castillo J, Comegna M, Quijada W, Jauvin V, Pinson P, Masquelier B, et al.: Surveillance of HIV type 1 drug resistance among naive patients from Venezuela. Aids Res Human Retroviruses 2009;25(12):1329-1333.
22. Viani RM, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, et al.: Prevalence of primary HIV-1 drug resistance among recently infected adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/Aids Interventions Study. J Infect Dis 2006;194(11):1505-1509. (Pubitemid 44851891)
23. Booth CL, Garcia-Diaz AM, Youle MS, Johnson MA, Phillips A, and Geretti AM: Prevalence and predictors of drug resistance in newly diagnosed HIV-1 infection. J Antimicrob Chemother 2007;59(3):517-524. (Pubitemid 47073459)
24. Hecht FMandGrantRM: Resistance testing in drug-naïveHIVinfected patients: Is it time? Clin Infect Dis 2005;41:1324-1325. (Pubitemid 41532677)
25. Sax PE, Islam R, Wanlesky RP, Losina E, Weinstein MC, Goldie SJ, et al.: Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis 2005;41:1316-1323. (Pubitemid 41532676)
26. Jain V, Sucupira C, Deeks S, Liegler T, Pilcher C, Grant R, et al.: Persistence of transmitted drug-resistance mutations in patients with acute HIV. 16th Conference on Retroviruses and Opportunistic Infections, February 8-February 11, 2009, Montreal, Canada. Poster #672.
27. Gadelha SR, Shindo N, Cruz JNM, Morgado MG, and Galvão-Castro B: Molecular epidemiology of human immunodeficiency vírus-1 in the State of Ceará , Northeast, Brazil. Mem Inst Oswaldo Cruz 2003;98(4):461-464.
28. Cavalcanti AMS, Lacerda HR, Brito AM, Pereira S, Medeiros D, and Oliveira S: Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast region of Brazil. Mem Inst Oswaldo Cruz 2007;102(7):785-792. (Pubitemid 350248734)